查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗凝固劑的全球市場調查報告-產業分析，規模，佔有率，成長，趨勢，2022年～2028年前的預測
市場調查報告書
商品編碼
1158875

抗凝固劑的全球市場調查報告-產業分析，規模，佔有率，成長，趨勢，2022年～2028年前的預測

Global Anticoagulant Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
出版日期: | 出版商: Value Market Research | 英文 269 Pages | 商品交期: 最快1-2個工作天內

價格

Value Market Research深入調查抗凝固劑的全球市場，並預測未來幾年行業將出現顯著增長。本研究報告提供全球抗凝固劑市場相關之完全產業分析，提供市場規模、市場佔有率、增長趨勢、2023年至2028年的預測等。該報告以詳細的市場介紹和突出報告關鍵增長數據的執行摘要為首。接續的章節討論市場價值鏈、波特五力模型和市場吸引力分析。同時還設立關於COVID-19影響分析的獨立章節，以了解市場如何應對疫情。

本報告的市場動態部分詳細介紹了當前的市場推動因素/阻礙、課題/風險和未來機遇。本節對企業戰略家和新產品開發部門非常有用。抗凝固劑全球市場調查將市場細分化，並根據收益和/或銷售額的視點提供市場規模。該數據地區細分，同時國家/地區細分。數據是通過深入的初級訪談和世界各地的行業專家收集而來。詳細的調查方法可以在樣本報告中找到。這些市場預測受到最新的社會、政治和經濟變化以及影響該抗凝固劑市場的當前市場動態所影響。

抗凝固劑市場報告的子章節提供市場競爭力調查，提供一些領先的市場參與者/製造商簡介。這些章節涵括可深入了解競爭對手的產品線、財務狀況、最新發展以及在行業中擁有最高市場佔有率公司所需的豐富資訊。

本報告的觀察對象國家如下列。

北美:美國，加拿大，墨西哥

歐洲:英國，德國，法國，義大利，俄羅斯，西班牙，其他的歐洲地區

亞太地區:中國，印度，日本，韓國，澳洲，其他APAC的各國

南美:巴西，阿根廷，秘魯，智利及其他的南美各國

中東·非洲地區:沙烏地阿拉伯，UAE，以色列，南非

本報告的市場區隔如下列。

各藥物類別

NOACs

肝素和LMWH

維他命K拮抗劑

其他

各給藥途徑

注射用抗凝固劑

口服抗凝固劑

各用途

中風

心房顫動

肺動脈栓塞(PE)

深部靜脈血栓症(DVT)

其他

目錄

第1章 序文

  • 本報告的內容
    • 目的
    • 主要讀者
    • 獨特的銷售主張(USP)和報價環
  • 調查範圍
  • 調查手法
    • 市場調查流程
    • 市場調查手法

第2章 摘要整理

  • 抗凝固劑市場概況
  • 抗凝固劑的全球市場概述

第3章 抗凝固劑:產業分析

  • 簡介
  • 抗凝固劑市場推動市場要素
  • 抗凝固劑市場阻礙市場要素
  • 抗凝固劑市場機會
  • 抗凝固劑市場趨勢
  • 抗凝固劑市場波特五力分析
  • 抗凝固劑市場魅力度分析
    • 各藥物類別市場魅力分析
    • 各給藥途徑的市場魅力分析
    • 各用途市場魅力分析
    • 各地區市場魅力分析

第4章 價值鏈分析

  • 抗凝固劑的價值鏈分析
  • 抗凝固劑原料的分析
    • 原料的清單
    • 抗凝固劑原料的製造原清單
    • 抗凝固劑主要原料的價格趨勢
  • 潛在的買主清單
  • 行銷流通管道
    • 直銷
    • 間接行銷
    • 行銷流通管道的新興國家市場開拓趨勢

第5章 抗凝固劑的全球市場分析:各藥物類別

  • 各藥物類別概要
  • 抗凝固劑的全球市場分析:各治療分類
  • NOACs的各地區市場分析
  • 肝素·LMWH的各地區市場分析
  • 維他命K拮抗劑的各地區市場分析
  • 各地區其他市場分析

第6章 抗凝固劑的全球市場分析:各給藥途徑

  • 各給藥途徑概要
  • 抗凝固劑的全球市場分析:各給藥途徑
  • 注射用抗凝固劑的各地區市場分析
  • 口服用抗凝固劑的各地區市場分析

第7章 抗凝固劑的全球市場分析:各用途

  • 各用途概要
  • 抗凝固劑的全球市場分析:各用途概要
  • 中風的各地區市場分析
  • 心房顫動的各地區市場分析
  • 肺動脈栓塞(PE)的各地區市場分析
  • 深部靜脈血栓症(DVT)的各地區市場分析
  • 各地區其他市場分析

第8章 抗凝固劑的全球市場分析:各地區

  • 各地區展望
  • 簡介
  • 北美
    • 概要
    • 北美的抗凝固劑市場估計:各國
    • 美國
    • 其他北美地區
  • 歐洲
    • 概要
    • 歐洲的抗凝固劑市場區隔估計
    • 歐洲的抗凝固劑市場估計:各國
    • 英國
    • 法國
    • 德國
    • 其他的歐洲地區
  • 亞太地區
    • 概要
    • 亞太地區的抗凝固劑市場區隔估計
    • 亞太地區的抗凝固劑的市場估計:各國
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 南美
    • 概要
    • 南美的抗凝固劑市場區隔估計
    • 南美的抗凝固劑的市場估計:各國
    • 巴西
    • 其他南美國家地區
  • 中東·非洲地區
    • 概要
    • 中東·非洲的抗凝固劑市場區隔估計
    • 中東·非洲的各國抗凝固劑的市場估計:各國
    • 中東地區
    • 非洲

第9章 抗凝固劑企業的競爭情形

  • 抗凝固劑市場競爭形勢
  • 夥伴關係/合作/協定
  • 合併·收購
  • 新產品的上市
  • 其他的開發

第10章 企業簡介

  • 企業佔有率分析
  • 市場集中度
  • Bayer AG
    • 企業概要
    • 產品介紹
    • 最近的開發情形
  • Aspen Holdings
    • 公司概要
    • 產品介紹
    • 最近的開發情形
  • Boehringer Ingelheim GmbH
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • Daiichi Sankyo Company, Limited
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • Bristol-Myers Squibb Company
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • GlaxoSmithKline
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • Pfizer, Inc.
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • Sanofi S.A.
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • Johnson & Johnson
    • 公司概要
    • 產品資訊
    • 最近的開發情形
  • Portola Pharmaceuticals, Inc.
    • 公司概要
    • 產品資訊
    • 最新資訊

在公司簡介中，財務細節和最近的發展基於可取得的現有信息，可能不包含非上市公司。

Product Code: VMR11211613

Value Market Research deeply researched the Global Anticoagulant Market to foresee a significant growth in the industry over the upcoming years. The global anticoagulant market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global anticoagulant market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this anticoagulant market.

The next sections of the anticoagulant market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Drug Class

NOACs

Heparin & LMWH

Vitamin K Antagonist

Others

By Route Of Administration

Injectable Anticoagulant

Oral Anticoagulant

By Application

Stroke

Atrial Fibrillation

Pulmonary Embolism (PE)

Deep Vein Thrombosis (DVT)

Others

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Anticoagulant Market
  • 2.2. Global Anticoagulant Market Snapshot

3 . ANTICOAGULANT - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Anticoagulant Market
  • 3.3. Market Restraints of Anticoagulant Market
  • 3.4. Opportunities of Anticoagulant Market
  • 3.5. Trends of Anticoagulant Market
  • 3.6. Porter's Five Force Analysis of Anticoagulant Market
  • 3.7. Anticoagulant Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Drug Class
    • 3.7.2 Market Attractive Analysis by Route Of Administration
    • 3.7.3 Market Attractive Analysis by Application
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Anticoagulant Value Chain Analysis
  • 4.2. Anticoagulant Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Anticoagulant Raw Material Manufactures List
    • 4.2.3. Price Trend of Anticoagulant Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY DRUG CLASS

  • 5.1 Overview by Drug Class
  • 5.2 Global Anticoagulant Market Analysis by Drug Class
  • 5.3 Market Analysis of NOACs by Regions
  • 5.4 Market Analysis of Heparin & LMWH by Regions
  • 5.5 Market Analysis of Vitamin K Antagonist by Regions
  • 5.6 Market Analysis of Others by Regions

6 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 6.1 Overview by Route Of Administration
  • 6.2 Global Anticoagulant Market Analysis by Route Of Administration
  • 6.3 Market Analysis of Injectable Anticoagulant by Regions
  • 6.4 Market Analysis of Oral Anticoagulant by Regions

7 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Global Anticoagulant Market Analysis by Application
  • 7.3 Market Analysis of Stroke by Regions
  • 7.4 Market Analysis of Atrial Fibrillation by Regions
  • 7.5 Market Analysis of Pulmonary Embolism (PE) by Regions
  • 7.6 Market Analysis of Deep Vein Thrombosis (DVT) by Regions
  • 7.7 Market Analysis of Others by Regions

8 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America Anticoagulant Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe Anticoagulant Market Estimate by Market Segment
    • 8.4.3. Europe Anticoagulant Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific Anticoagulant Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Anticoagulant Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America Anticoagulant Market Estimate by Market Segment
    • 8.6.3. Latin America Anticoagulant Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa Anticoagulant Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Anticoagulant Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE ANTICOAGULANT COMPANIES

  • 9.1. Anticoagulant Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ANTICOAGULANT INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Bayer AG
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Aspen Holdings
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Boehringer Ingelheim GmbH
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Daiichi Sankyo Company, Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Bristol-Myers Squibb Company
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. GlaxoSmithKline
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Pfizer, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financials
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Sanofi S.A.
    • 10.10.1. Company Overview
    • 10.10.2. Financials
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Johnson & Johnson
    • 10.11.1. Company Overview
    • 10.11.2. Financials
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Portola Pharmaceuticals, Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Financials
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Global Anticoagulant Market Snapshot
  • Drivers of The Global Anticoagulant Market Impact Analysis
  • Restraints of The Global Anticoagulant Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Anticoagulant Market Analysis by Drug Class (USD MN)
  • Global Anticoagulant Market Analysis in NOACs by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Heparin & LMWH by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Vitamin K Antagonist by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Route Of Administration (USD MN)
  • Global Anticoagulant Market Analysis in Injectable Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Oral Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Application (USD MN)
  • Global Anticoagulant Market Analysis in Stroke by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Atrial Fibrillation by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Pulmonary Embolism (PE) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Deep Vein Thrombosis (DVT) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Global Anticoagulant Market by Geography (USD MN)
  • North America Anticoagulant Market Analysis by Drug Class (USD MN)
  • North America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • North America Anticoagulant Market Estimate by Application (USD MN)
  • North America Anticoagulant Market Estimate by Country (USD MN)
  • United State Anticoagulant Market Analysis by Drug Class (USD MN)
  • United State Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • United State Anticoagulant Market Analysis by Application (USD MN)
  • Rest of North America Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of North America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of North America Anticoagulant Market Estimate by Application(USD MN)
  • Europe Anticoagulant Market Analysis by Drug Class (USD MN)
  • Europe Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Europe Anticoagulant Market Estimate by Application (USD MN)
  • United Kingdom Anticoagulant Market Analysis by Drug Class (USD MN)
  • United Kingdom Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • United Kingdom Anticoagulant Market Estimate by Application (USD MN)
  • France Anticoagulant Market Analysis by Drug Class (USD MN)
  • France Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • France Anticoagulant Market Estimate by Application (USD MN)
  • Germany Anticoagulant Market Analysis by Drug Class (USD MN)
  • Germany Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Germany Anticoagulant Market Estimate by Application (USD MN)
  • Rest of Europe Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of Europe Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of Europe Anticoagulant Market Estimate by Application (USD MN)
  • Asia Pacific Anticoagulant Market Analysis by Drug Class (USD MN)
  • Asia Pacific Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Asia Pacific Anticoagulant Market Estimate by Application (USD MN)
  • Asia Pacific Anticoagulant Market Estimate by Country (USD MN)
  • China Anticoagulant Market Analysis by Drug Class (USD MN)
  • China Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • China Anticoagulant Market Estimate by Application (USD MN)
  • Japan Anticoagulant Market Analysis by Drug Class (USD MN)
  • Japan Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Japan Anticoagulant Market Estimate by Application (USD MN)
  • India Anticoagulant Market Analysis by Drug Class (USD MN)
  • India Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • India Anticoagulant Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of Asia Pacific Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of Asia Pacific Anticoagulant Market Estimate by Application (USD MN)
  • Latin America Anticoagulant Market Analysis by Drug Class (USD MN)
  • Latin America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Latin America Anticoagulant Market Estimate by Application (USD MN)
  • Latin America Anticoagulant Market Estimate by Country (USD MN)
  • Brazil Anticoagulant Market Analysis by Drug Class (USD MN)
  • Brazil Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Brazil Anticoagulant Market Estimate by Application (USD MN)
  • Rest of Latin America Anticoagulant Market Analysis by Drug Class (USD MN)
  • Rest of Latin America Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Rest of Latin America Anticoagulant Market Estimate by Application (USD MN)
  • Middle East & Africa Anticoagulant Market Analysis by Drug Class (USD MN)
  • Middle East & Africa Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Middle East & Africa Anticoagulant Market Estimate by Application (USD MN)
  • Middle East & Africa Anticoagulant Market Estimate by Country (USD MN)
  • Middle East Anticoagulant Market Analysis by Drug Class (USD MN)
  • Middle East Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Middle East Anticoagulant Market Estimate by Application (USD MN)
  • Africa Anticoagulant Market Analysis by Drug Class (USD MN)
  • Africa Anticoagulant Market Estimate by Route Of Administration (USD MN)
  • Africa Anticoagulant Market Estimate by Application (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis

LIST OF FIGURES

  • Research Scope of Anticoagulant Report
  • Market Research Process
  • Market Research Methodology
  • Global Anticoagulant Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Drug Class
  • Market Attractiveness Analysis by Route Of Administration
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Anticoagulant Market Analysis by Drug Class (USD MN)
  • Global Anticoagulant Market Analysis in NOACs by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Heparin & LMWH by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Vitamin K Antagonist by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Route Of Administration (USD MN)
  • Global Anticoagulant Market Analysis in Injectable Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Oral Anticoagulant by Geography (USD MN)
  • Global Anticoagulant Market Analysis by Application (USD MN)
  • Global Anticoagulant Market Analysis in Stroke by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Atrial Fibrillation by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Pulmonary Embolism (PE) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Deep Vein Thrombosis (DVT) by Geography (USD MN)
  • Global Anticoagulant Market Analysis in Others by Geography (USD MN)
  • Latin America Anticoagulant Market by Revenue
  • Middle East & Africa Anticoagulant Market by Revenue
  • Recent Development in Anticoagulant Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.